Thubrikar Aortic Valve, Inc.
Our next-gen Transcatheter Aortic Valve Implantation (TAVI) system was designed for durability, and has demonstrated superior valve performance in patients.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Collegeville, PA, USA
- Currency USD
- Founded October 2010
- Employees 5
- Incorporation Type C-corp
- Website TAVI.us
Company Summary
Dr. Thubrikar designed the Optimum TAVI System for maximum durability, and precise delivery. We began a European clinical trial in 2022, and all 12 patients are doing very well. In 2018, our first patient was implanted in Brazil via Labcor Laboratorios’ trial, and is also well. Superior valve performance has been shown in patients, as was more durability in preclinical tests (mimics 24 Yrs in the AWT "Durability Test", and less calcium in sheep).
Team
-
President, Founder, and Board DirectorDr. Thubrikar is a world-renowned authority on the aortic valve. He previously worked as Director of BME at South Dakota School of Mines and Technology; as Edwards Distinguished Research Scientist at Edwards Lifesciences Corp.; as Director of BME at The Heineman Medical Research Center; and as Director of Surgical Research in the Department of Surgery at UVA. Dr. Thubrikar authored “Vascular Mechanics and Pathology” and “The Aortic Valve”.
-
Co-Founder, Counsel and Corporate SecretaryMr. Heble is a registered patent attorney with significant experience handling intellectual property matters related to a wide range of life science-based technologies. Mr. Heble began his legal career with an Am Law 100 law firm, and most recently held the position of Senior Patent Counsel for a Fortune 500 consumer products company.
-
Co-Founder, Vice President of Business DevelopmentMr. Wadke leads the strategic operations of the Company with over 20+ years of cross-functional experience. Prior to the Company, he consulted for early-stage pharmaceutical companies. From 2007-2009, he worked for VGX Pharma in Business Development, including its integration of an acquisition and its merger with Inovio BioMedical (NYSEMKT:INO). He previously worked in financial, marketing, and strategy roles at J.P. Morgan and MB Financial.
-
Director of Quality Assurance and Regulatory AffairsOver 30 years of experience in the medical device industry. In addition to Regulatory experience, he brings a deep understanding of, and experience in, Quality Systems, Clinical Studies, Engineering, and Manufacturing. He has worked with many medical devices from GE Healthcare, Medtronic, Terumo, Greatbatch, and several early-stage medical device OEMs. He has published several scientific papers and is named on several medical device patents.
-
Evan RoushAssociate Director of Product DevelopmentBefore joining our Company in 2019, Mr. Roush was a Research Engineer for 6 years at Penn State Hershey College of Medicine, including in Orthopedics (biomaterials, biomechanics, internal and external implants, joint replacements, fracture fixations, and soft tissue reconstructions.) and Artificial Organs (R&D of ventricular assist devices and mechanical heart valves. He has co-authored several Orthopedics publications, and conference abstracts.
Advisors
-
Susheel KodaliUnconfirmed -
Vishal ThubrikarUnconfirmed
Previous Investors
-
TAVI physician, St. Mary's Hospital -
Lehigh Valley Angel Investors - Matt BuhayUnconfirmed
James Wudel, Heart SurgeonUnconfirmed
China Cardiovascular Research Foundation (CCRF) - Dr. Tony ZhuUnconfirmed -
Labcor LaboratoriosUnconfirmed
Heartland AngelsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.